Knowledge

Endothelial progenitor cell

Source đź“ť

634:
effect of infusing ex-vivo expanded bone marrow EPCs and culture enriched EPCs derived from peripheral blood into 20 patients with acute myocardial infarction (MI). After four months, significant enhancements were found in ventricular ejection fraction, cardiac geometry, coronary blood flow reserve, and myocardial viability (Shantsila, Watson, & Lip). A similar study looked at the therapeutic effects of EPCs on leg ischemia caused by severe peripheral artery disease. The study injected a sample of EPC rich blood into the gastrocnemius muscles of 25 patients. After 24 weeks an increased number of collateral vessels and improved recovery in blood perfusion was observed. Rest pain and pain-free walking were also noted to have improved
70:
instead acting via paracrine methods to provide support for the resident endothelial cells. While some other authors have contested these, and maintained that they are true EPCs, many investigators have begun to term these cells colony forming unit-Hill cells (CFU-Hill) or circulating angiogenic cells (CAC) instead (depending on the method of isolation), highlighting their role as hematopoietic
651:. These observations contradict sprouting angiogenesis driven by EPCs. Taken together with the inability to find bone-marrow derived endothelium in new vasculature, there is now little material support for postnatal vasculogenesis. Instead, angiogenesis is likely driven by a process of physical force. 66:-like cells; cells which could give rise to functional vasculature in adults. The existence of endothelial progenitor cells has been posited since the mid-twentieth century, however their existence was not confirmed until the 1990s when Asahara et al. published the discovery of the first putative EPC. 1640:
Lyden, D.; Hattori, K.; Dias, S.; Costa, C.; Blaikie, P.; Butros, L.; Chadburn, A.; Heissig, B.; Marks, W.; Witte, L.; Wu, Y.; Hicklin, D.; Zhu, Z.; Hackett, N. R.; Crystal, R. G.; Moore, M. A. S.; Hajjar, K. A.; Manova, K.; Benezra, R.; Rafii, S. (2001). "Impaired recruitment of bone-marrow-derived
633:
A number of small phase clinical trials have begun to point to EPCs as a potential treatment for various cardiovascular diseases (CVDs). For instance, the year long "Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction" (TOPCARE-AMI) studied the therapeutic
604:
Recently it has been found that miRNAs regulate EPC biology and tumour angiogenesis. This work by Plummer et al. found that in particular targeting of the miRNAs miR-10b and miR-196b led to significant defects in angiogenesis-mediated tumor growth by decreasing the mobilization of proangiogenic EPCs
217:
EPCs also have variable phenotypic markers used for identification. Unfortunately, there are no unique markers for endothelial progenitors that are not shared with other endothelial or hematopoietic cells, which has contributed to the historical controversy surrounding the field. A detailed overview
554:
are a late outgrowth cell type; that is, they are only isolated after significantly longer culture than CFU-Hill cells. ECFCs are isolated by plating peripheral blood mononuclear fraction on collagen-coated plates, removing non-adherent cells, and culturing for weeks until the emergence of colonies
69:
Recently, controversy has developed over the definition of true endothelial progenitors. Although bone marrow-derived cells do appear to localize to injured vessels and promote an angiogenic switch, other studies have suggested these cells do not contribute directly to the functional endothelium,
592:
Endothelial progenitor cells are likely important in tumour growth and are thought to be critical for metastasis and the angiogenesis. A large amount of research has been done on CFU-Hill bone marrow-derived putative EPCs. Ablation of the endothelial progenitor cells in the bone marrow lead to a
612:(HUVECs) to have a capacity for tumor migration and neoangiogenesis even greater than that of other CD34+ hematopoietic cells when implanted in immunodeficient mice, suggesting the endothelial progenitors play a key role, but further supporting the importance of both cell types as targets for 629:
between these outcomes and circulating endothelial progenitor cell numbers were scant in the original research. Endothelial progenitor cells are mobilized after a myocardial infarction, and that they function to restore the lining of blood vessels that are damaged during the heart attack.
542:
A similar method is to culture the peripheral blood mononuclear fraction in supplemented endothelial growth medium, removing the non-adherent cells, and isolating the remaining. While these cells display some endothelial characteristics, they do not form colonies.
533:
As originally isolated by Asahara et al., the CFU-Hill population is an early outgrowth, formed by plating peripheral blood mononuclear cells on fibronectin-coated dishes, allowing adhesion and depleting non-adherent cells, and isolating discrete colonies.
81:-like expression patterns, and support the existence of a separate population of progenitors, the late outgrowth, or endothelial colony forming cell (ECFC). Furthermore, early outgrowth cells maintain other monocyte functions such as high Dil-Ac-LDL and 103:
represent a distinct population that has been found to have the potential to differentiate and promote vessel repair. ECFCs are now known to be tissue-resident progenitor cells in adults that maintain some vasculogenic ability.
1735:
Bieback K, Vinci M, Elvers-Hornung S, Bartol A, Gloe T, Czabanka M, KlĂĽter H, Augustin H, Vajkoczy P (2013). "Recruitment of human cord blood-derived endothelial colony-forming cells to sites of tumor angiogenesis".
646:
remains unclear. Blood vessels have been seen entering ischemic tissue in a process driven by mechanically forced ingress of existing capillaries into the avascular region, and importantly, instead of through
624:
Higher levels of circulating "endothelial progenitor cells" were detected in the bloodstream of patients, predicted better outcomes, and patients experienced fewer repeat heart attacks, though statistical
777:
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997). "Isolation of putative progenitor endothelial cells for angiogenesis".
38:. Outgrowth endothelial cells are an EPC subtype committed to endothelial cell formation. Despite the history and controversy, the EPC in all its forms remains a promising target of 555:
with a distinctive cobblestone morphology. These cells are phenotypically similar to endothelial cells and have been shown to create vessel-like structures in vitro and in vivo.
1593:"Using the Transcription Factor Inhibitor of DNA Binding 1 to Selectively Target Endothelial Progenitor Cells Offers Novel Strategies to Inhibit Tumor Angiogenesis and Growth" 601:) has been used as a marker for these cells; this allows for tracking EPCs from the bone marrow to the blood to the tumour-stroma and even incorporated in tumour vasculature. 112:
By method of isolation and cell function, three main populations of putative adult EPCs have been described. The behavior of the cells can be found in the following table.
567:(or their in vitro counterpart, blast-colony forming cells) are cells believed to give rise to both the endothelial and hematopoietic systems during early development. 820:
Yoder MC, Ingram DA (2009). "Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system".
983:"Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas" 924:"Reply to Kerbel et al.: EPCs are again claimed to be essential in yet other models despite the irreproducibility of the original experiments introducing them" 676: 593:
significant decrease in tumour growth and vasculature development. This indicates that endothelial progenitor cells present novel therapeutic targets.
605:
to the tumour. These findings indicate that directed targeting these miRNAs in EPCs may result in a novel strategy for inhibiting tumor angiogenesis.
1549:
Milosevic, Vladan; Edelmann, Reidunn J.; Fosse, Johanna Hol; Ă–stman, Arne; Akslen, Lars A. (2022), Akslen, Lars A.; Watnick, Randolph S. (eds.),
702: 1949:
Molecular Phenotypes of Endothelial Cells in Malignant Tumors. In: Akslen, L.A., Watnick, R.S. (eds) Biomarkers of the Tumor Microenvironment
865:"Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth" 563:
Certain developmental cells may be similar to or the same as other endothelial progenitors, though not typically referred to as EPCs.
1199:"Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture" 1148:"Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities" 1570: 609: 1330:(2008). "Endothelial progenitor cells, angioblasts, and angiogenesis – old terms reconsidered from a current perspective". 981:
Kerbel RS, Benezra R, Lyden DC, Hattori K, Heissig B, Nolan DJ, Mittal V, Shaked Y, Dias S, Bertolini F, Rafii S (2008).
1240:"Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood" 571:
are believed to be a form of early progenitor or stem cell which gives rise to the endothelium alone. More recently,
551: 100: 1853:
Kilarski WW; et al. (2009). "Biomechanical regulation of blood vessel growth during tissue vascularization".
1449:
Gao D; et al. (2008). "Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis".
1327: 1238:
Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC (2004).
863:
Purhonen S, Palm J, Rossi D, Kaskenpää N, Rajantie I, Ylä-Herttuala S, Alitalo K, Weissman IL, Salven P (2008).
1502:"Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization" 30:) is a term that has been applied to multiple different cell types that play roles in the regeneration of the 1414:
Cossu G, Bianco P (2003). "Mesoangioblasts – vascular progenitors for extravascular mesodermal tissues".
698:"Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy" 77:
Molecular genetic analysis of early outgrowth putative EPC populations suggests they do indeed have
613: 1948: 648: 1146:
Medina RJ, O'Neill CL, Sweeney M, Guduric-Fuchs J, Gardiner TA, Simpson DA, Stitt AW (2010).
922:
Salven, P.; Purhonen, S.; Rossi, D.; Yla-Herttuala, S.; Alitalo, K.; Weissman, I. L. (2008).
476: 442: 55: 39: 17: 1967: 1458: 994: 935: 876: 51: 8: 1462: 998: 939: 880: 89:
expression. These original, early outgrowth, CFU-Hill or CACs are also shown to express
1878: 1666: 1617: 1592: 1526: 1501: 1482: 1391: 1366: 1174: 1147: 1123: 1098: 1017: 982: 966: 923: 899: 864: 845: 802: 94: 1919: 1870: 1835: 1794: 1753: 1717: 1712: 1658: 1641:
endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth".
1622: 1566: 1531: 1474: 1431: 1396: 1382: 1347: 1305: 1261: 1220: 1179: 1128: 1070: 1022: 953: 904: 837: 794: 759: 721: 697: 1882: 1670: 1486: 849: 806: 1909: 1862: 1825: 1784: 1745: 1707: 1697: 1650: 1612: 1604: 1558: 1521: 1513: 1466: 1423: 1386: 1378: 1339: 1295: 1251: 1210: 1169: 1159: 1118: 1110: 1060: 1012: 1002: 961: 943: 894: 884: 829: 786: 751: 711: 1702: 1685: 1608: 1686:"MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells" 833: 790: 572: 86: 1562: 667:
of the ectopic endometrial tissue originates from endothelial progenitor cells.
1830: 1813: 1749: 1256: 1239: 755: 564: 1952: 1947:
Milosevic, V., Edelmann, R.J., Fosse, J.H., Ă–stman, A., Akslen, L.A. (2022).
1550: 1427: 1343: 1961: 1323: 1309: 957: 660: 643: 59: 35: 1914: 1897: 1470: 1365:
Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B, Case J (2009).
1007: 948: 889: 1923: 1874: 1839: 1798: 1757: 1721: 1662: 1626: 1535: 1478: 1435: 1400: 1351: 1265: 1224: 1183: 1164: 1132: 1074: 1065: 1048: 1026: 908: 841: 763: 725: 626: 1300: 1283: 1215: 1198: 798: 1789: 1772: 1197:
Zhang SJ, Zhang H, Wei YJ, Su WJ, Liao ZK, Hou M, Zhou JY, Hu SS (2006).
716: 664: 568: 306: 31: 1654: 1517: 576: 63: 1773:"Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes" 1114: 1145: 82: 1866: 696:
Medina RJ, O'Neill CL, Humphreys MW, Gardiner TA, Stitt AW (2010).
78: 695: 50:
Developmentally, the endothelium arises in close contact with the
742:
Pelosi E, Castelli G, Testa U (2014). "Endothelial progenitors".
71: 1734: 1282:
Parham, Kate A.; Pitson, Stuart M.; Bonder, Claudine S. (2014).
921: 1551:"Molecular Phenotypes of Endothelial Cells in Malignant Tumors" 425: 408: 1099:"Circulating and tissue resident endothelial progenitor cells" 1049:"Working hypothesis to redefine endothelial progenitor cells" 776: 459: 391: 374: 323: 289: 255: 1548: 1557:, Cham: Springer International Publishing, pp. 31–52, 1284:"Regulation of EPCs: The Gateway to Blood Vessel Formation" 493: 357: 340: 272: 238: 97:
receptor expressed by monocytes but not endothelial cells.
90: 1814:"Endothelial progenitor cells in cardiovascular disorders" 862: 1898:"Vasculogenesis: A new piece of the endometriosis puzzle" 1364: 980: 598: 594: 510: 218:
of current markers can be found in the following table.
575:
have been theorized as a cell giving rise to multiple
1639: 1322: 1237: 1046: 677:
List of human cell types derived from the germ layers
1895: 1590: 1896:Laschke, M. W.; Giebels, C.; Menger, M. D. (2011). 741: 1281: 546: 1367:"Endothelial progenitor cells: identity defined?" 663:, it appears that up to 37% of the microvascular 619: 1959: 703:Investigative Ophthalmology & Visual Science 1196: 1047:Prater DN, Case J, Ingram DA, Yoder MC (2007). 928:Proceedings of the National Academy of Sciences 74:cells involved in promoting new vessel growth. 1940:Aird, William C. "Blood Endothelial Cells" in 1358: 537: 1818:Journal of the American College of Cardiology 1277: 1275: 528: 1591:Mellick As; Plummer PN; et al. (2010). 1092: 1090: 1088: 1086: 1084: 1042: 1040: 1038: 1036: 737: 735: 642:The role of endothelial progenitor cells in 1953:https://doi.org/10.1007/978-3-030-98950-7_3 1852: 1811: 1728: 1413: 1316: 1096: 856: 819: 689: 1683: 1272: 1231: 1139: 770: 45: 1944:. Boca Raton: Taylor & Francis, 2005. 1913: 1829: 1788: 1711: 1701: 1616: 1525: 1407: 1390: 1299: 1255: 1214: 1190: 1173: 1163: 1122: 1081: 1064: 1033: 1016: 1006: 974: 965: 947: 915: 898: 888: 732: 715: 1770: 1555:Biomarkers of the Tumor Microenvironment 1499: 813: 654: 637: 1942:Endothelial Cells In Health and Disease 587: 58:, led to a belief and search for adult 1960: 610:human umbilical vein endothelial cells 1448: 1326:, Moore J, Herbert A, Ma D, Boehm M, 13: 1934: 202:Paracrine support of angiogenesis 107: 14: 1979: 1812:Shantsila E; et al. (2007). 188:Homing to ischemic sites in vivo 174:In vivo de novo vessel formation 1684:Plummer PN; et al. (2012). 1383:10.1111/j.1582-4934.2008.00598.x 552:Endothelial colony forming cells 233:Endothelial colony forming cell 127:Endothelial colony forming cell 101:Endothelial colony forming cells 1889: 1846: 1805: 1777:New England Journal of Medicine 1764: 1677: 1633: 1584: 1542: 1493: 1442: 547:Endothelial colony forming cell 1771:Werner N; et al. (2005). 1500:Nolan DJ; et al. (2007). 620:Role in cardiovascular disease 558: 118:Behaviour .. \\ .. Population 1: 1703:10.1158/0008-5472.CAN-12-0271 1609:10.1158/0008-5472.CAN-10-1142 993:(34): E54, author reply E55. 682: 608:Studies have shown ECFCs and 54:. This, and the existence of 1097:Basile DP, Yoder MC (2014). 834:10.1097/MOH.0b013e32832bbcab 791:10.1126/science.275.5302.964 230:Circulating angiogenic cell 132:Clonal proliferative status 124:Circulating angiogenic cell 7: 1563:10.1007/978-3-030-98950-7_3 670: 582: 538:Circulating angiogenic cell 227:Colony forming unit – Hill 224:Marker .. \\ .. Population 121:Colony forming unit – Hill 24:Endothelial progenitor cell 10: 1984: 1831:10.1016/j.jacc.2006.09.050 1750:10.1016/j.jcyt.2013.01.215 1257:10.1182/blood-2004-04-1396 987:Proc. Natl. Acad. Sci. USA 869:Proc. Natl. Acad. Sci. USA 756:10.1016/j.bcmd.2013.11.004 595:Inhibitor of DNA Binding 1 529:Colony forming unit – Hill 15: 1902:Human Reproduction Update 1428:10.1016/j.gde.2003.08.001 1344:10.1016/j.tcm.2007.12.002 160:In vitro tube formation 16:Not to be confused with 1506:Genes & Development 1471:10.1126/science.1150224 1008:10.1073/pnas.0804876105 949:10.1073/pnas.0805971105 890:10.1073/pnas.0710516105 614:pharmacological therapy 46:History and controversy 1416:Curr. Opin. Genet. Dev 1332:Trends Cardiovasc. Med 1288:New Journal of Science 1165:10.1186/1755-8794-3-18 1066:10.1038/sj.leu.2404676 649:sprouting angiogenesis 428:(KDR/Flk1) expression 1915:10.1093/humupd/dmr023 1713:10536/DRO/DU:30063097 1216:10.1038/sj.cr.7310075 655:Role in endometriosis 638:Role in wound healing 477:von Willebrand factor 56:hemogenic endothelium 40:regenerative medicine 18:Endothelial stem cell 1790:10.1056/NEJMoa043814 744:Blood Cells Mol. Dis 717:10.1167/iovs.09-4951 588:Role in tumor growth 52:hematopoietic system 1655:10.1038/nm1101-1194 1463:2008Sci...319..195G 1301:10.1155/2014/972043 999:2008PNAS..105E..54K 940:2008PNAS..105E..55S 881:2008PNAS..105.6620P 822:Curr. Opin. Hematol 343:(PECAM) expression 1951:. Springer, Cham. 1518:10.1101/gad.436307 394:(ckit) expression 146:Replating ability 95:lipopolysaccharide 1572:978-3-030-98950-7 1371:J. Cell. Mol. Med 1115:10.1002/jcp.24423 526: 525: 215: 214: 1975: 1928: 1927: 1917: 1893: 1887: 1886: 1850: 1844: 1843: 1833: 1809: 1803: 1802: 1792: 1783:(10): 999–1007. 1768: 1762: 1761: 1732: 1726: 1725: 1715: 1705: 1681: 1675: 1674: 1649:(11): 1194–201. 1637: 1631: 1630: 1620: 1588: 1582: 1581: 1580: 1579: 1546: 1540: 1539: 1529: 1497: 1491: 1490: 1457:(5860): 195–98. 1446: 1440: 1439: 1411: 1405: 1404: 1394: 1362: 1356: 1355: 1320: 1314: 1313: 1303: 1279: 1270: 1269: 1259: 1235: 1229: 1228: 1218: 1194: 1188: 1187: 1177: 1167: 1143: 1137: 1136: 1126: 1103:J. Cell. Physiol 1094: 1079: 1078: 1068: 1044: 1031: 1030: 1020: 1010: 978: 972: 971: 969: 951: 919: 913: 912: 902: 892: 860: 854: 853: 817: 811: 810: 785:(5302): 964–67. 774: 768: 767: 739: 730: 729: 719: 693: 221: 220: 115: 114: 1983: 1982: 1978: 1977: 1976: 1974: 1973: 1972: 1958: 1957: 1937: 1935:Further reading 1932: 1931: 1894: 1890: 1867:10.1038/nm.1985 1855:Nature Medicine 1851: 1847: 1810: 1806: 1769: 1765: 1733: 1729: 1690:Cancer Research 1682: 1678: 1643:Nature Medicine 1638: 1634: 1603:(18): 7273–82. 1597:Cancer Research 1589: 1585: 1577: 1575: 1573: 1547: 1543: 1512:(12): 1546–58. 1498: 1494: 1447: 1443: 1412: 1408: 1363: 1359: 1321: 1317: 1280: 1273: 1236: 1232: 1195: 1191: 1144: 1140: 1095: 1082: 1045: 1034: 979: 975: 920: 916: 875:(18): 6620–25. 861: 857: 818: 814: 775: 771: 740: 733: 710:(11): 5906–13. 694: 690: 685: 673: 657: 640: 622: 590: 585: 573:mesoangioblasts 561: 549: 540: 531: 110: 108:Classifications 85:uptake and low 48: 21: 12: 11: 5: 1981: 1971: 1970: 1956: 1955: 1945: 1936: 1933: 1930: 1929: 1888: 1845: 1804: 1763: 1727: 1676: 1632: 1583: 1571: 1541: 1492: 1441: 1406: 1357: 1315: 1271: 1250:(9): 2752–60. 1230: 1189: 1152:BMC Med. Genom 1138: 1080: 1059:(6): 1141–49. 1032: 973: 914: 855: 812: 769: 731: 687: 686: 684: 681: 680: 679: 672: 669: 656: 653: 639: 636: 621: 618: 589: 586: 584: 581: 565:Hemangioblasts 560: 557: 548: 545: 539: 536: 530: 527: 524: 523: 520: 517: 514: 506: 505: 502: 499: 496: 490: 489: 486: 483: 480: 473: 472: 469: 466: 463: 456: 455: 452: 449: 446: 439: 438: 435: 432: 429: 422: 421: 418: 415: 412: 405: 404: 401: 398: 395: 388: 387: 384: 381: 378: 371: 370: 367: 364: 361: 354: 353: 350: 347: 344: 337: 336: 333: 330: 327: 320: 319: 316: 313: 310: 303: 302: 299: 296: 293: 286: 285: 282: 279: 276: 269: 268: 265: 262: 259: 252: 251: 248: 245: 242: 235: 234: 231: 228: 225: 213: 212: 209: 206: 203: 199: 198: 195: 192: 189: 185: 184: 181: 178: 175: 171: 170: 167: 164: 161: 157: 156: 153: 150: 147: 143: 142: 139: 136: 133: 129: 128: 125: 122: 119: 109: 106: 47: 44: 9: 6: 4: 3: 2: 1980: 1969: 1966: 1965: 1963: 1954: 1950: 1946: 1943: 1939: 1938: 1925: 1921: 1916: 1911: 1908:(5): 628–36. 1907: 1903: 1899: 1892: 1884: 1880: 1876: 1872: 1868: 1864: 1861:(6): 657–64. 1860: 1856: 1849: 1841: 1837: 1832: 1827: 1824:(7): 741–52. 1823: 1819: 1815: 1808: 1800: 1796: 1791: 1786: 1782: 1778: 1774: 1767: 1759: 1755: 1751: 1747: 1744:(6): 726–39. 1743: 1739: 1731: 1723: 1719: 1714: 1709: 1704: 1699: 1696:(1): 341–52. 1695: 1691: 1687: 1680: 1672: 1668: 1664: 1660: 1656: 1652: 1648: 1644: 1636: 1628: 1624: 1619: 1614: 1610: 1606: 1602: 1598: 1594: 1587: 1574: 1568: 1564: 1560: 1556: 1552: 1545: 1537: 1533: 1528: 1523: 1519: 1515: 1511: 1507: 1503: 1496: 1488: 1484: 1480: 1476: 1472: 1468: 1464: 1460: 1456: 1452: 1445: 1437: 1433: 1429: 1425: 1422:(5): 537–42. 1421: 1417: 1410: 1402: 1398: 1393: 1388: 1384: 1380: 1377:(1): 87–102. 1376: 1372: 1368: 1361: 1353: 1349: 1345: 1341: 1337: 1333: 1329: 1325: 1319: 1311: 1307: 1302: 1297: 1293: 1289: 1285: 1278: 1276: 1267: 1263: 1258: 1253: 1249: 1245: 1241: 1234: 1226: 1222: 1217: 1212: 1209:(6): 577–84. 1208: 1204: 1200: 1193: 1185: 1181: 1176: 1171: 1166: 1161: 1157: 1153: 1149: 1142: 1134: 1130: 1125: 1120: 1116: 1112: 1108: 1104: 1100: 1093: 1091: 1089: 1087: 1085: 1076: 1072: 1067: 1062: 1058: 1054: 1050: 1043: 1041: 1039: 1037: 1028: 1024: 1019: 1014: 1009: 1004: 1000: 996: 992: 988: 984: 977: 968: 963: 959: 955: 950: 945: 941: 937: 933: 929: 925: 918: 910: 906: 901: 896: 891: 886: 882: 878: 874: 870: 866: 859: 851: 847: 843: 839: 835: 831: 828:(4): 269–73. 827: 823: 816: 808: 804: 800: 796: 792: 788: 784: 780: 773: 765: 761: 757: 753: 750:(4): 186–94. 749: 745: 738: 736: 727: 723: 718: 713: 709: 705: 704: 699: 692: 688: 678: 675: 674: 668: 666: 662: 661:endometriosis 652: 650: 645: 644:wound healing 635: 631: 628: 617: 615: 611: 606: 602: 600: 596: 580: 578: 574: 570: 566: 556: 553: 544: 535: 521: 518: 515: 512: 508: 507: 503: 500: 497: 495: 492: 491: 487: 484: 481: 478: 475: 474: 470: 467: 464: 461: 458: 457: 453: 450: 447: 444: 441: 440: 436: 433: 430: 427: 424: 423: 419: 416: 413: 410: 407: 406: 402: 399: 396: 393: 390: 389: 385: 382: 379: 376: 373: 372: 368: 365: 362: 359: 356: 355: 351: 348: 345: 342: 339: 338: 334: 331: 328: 325: 322: 321: 317: 314: 311: 308: 305: 304: 300: 297: 294: 291: 288: 287: 283: 280: 277: 274: 271: 270: 266: 263: 260: 257: 254: 253: 249: 246: 243: 240: 237: 236: 232: 229: 226: 223: 222: 219: 210: 207: 204: 201: 200: 196: 193: 190: 187: 186: 182: 179: 176: 173: 172: 168: 165: 162: 159: 158: 154: 151: 148: 145: 144: 140: 137: 134: 131: 130: 126: 123: 120: 117: 116: 113: 105: 102: 98: 96: 92: 88: 84: 80: 75: 73: 67: 65: 61: 60:hemangioblast 57: 53: 43: 41: 37: 36:blood vessels 33: 29: 25: 19: 1941: 1905: 1901: 1891: 1858: 1854: 1848: 1821: 1817: 1807: 1780: 1776: 1766: 1741: 1737: 1730: 1693: 1689: 1679: 1646: 1642: 1635: 1600: 1596: 1586: 1576:, retrieved 1554: 1544: 1509: 1505: 1495: 1454: 1450: 1444: 1419: 1415: 1409: 1374: 1370: 1360: 1338:(2): 45–51. 1335: 1331: 1318: 1291: 1287: 1247: 1243: 1233: 1206: 1202: 1192: 1155: 1151: 1141: 1109:(1): 10–16. 1106: 1102: 1056: 1052: 990: 986: 976: 931: 927: 917: 872: 868: 858: 825: 821: 815: 782: 778: 772: 747: 743: 707: 701: 691: 658: 641: 632: 627:correlations 623: 607: 603: 591: 562: 550: 541: 532: 216: 111: 99: 76: 68: 49: 27: 23: 22: 1968:Blood cells 1738:Cytotherapy 934:(34): E55. 665:endothelium 569:Angioblasts 559:Development 479:expression 462:expression 445:expression 411:expression 377:expression 360:expression 326:expression 309:expression 307:VE-cadherin 292:expression 275:expression 258:expression 241:expression 32:endothelial 1578:2022-07-13 1324:Kovacic JC 683:References 577:mesodermal 64:angioblast 42:research. 34:lining of 1328:Graham RM 1310:2356-7740 958:0027-8424 579:tissues. 83:India ink 1962:Category 1924:21586449 1883:13354598 1875:19483693 1840:17306702 1799:16148285 1758:23491253 1722:22836757 1671:12961562 1663:11689883 1627:20807818 1536:17575055 1487:12577022 1479:18187653 1436:14550421 1401:19067770 1352:18308194 1294:: 1–16. 1266:15226175 1225:16775629 1203:Cell Res 1184:20465783 1133:23794280 1075:17392816 1053:Leukemia 1027:18715995 909:18443294 850:24786196 842:19417649 807:44878638 764:24332583 726:20554606 671:See also 583:Function 79:monocyte 1618:3058751 1527:1891431 1459:Bibcode 1451:Science 1392:3823038 1175:2881111 1124:3908443 1018:2527966 995:Bibcode 967:2527967 936:Bibcode 900:2365563 877:Bibcode 799:9020076 779:Science 513:uptake 504:Bright 501:Bright 498:Bright 72:myeloid 1922:  1881:  1873:  1838:  1797:  1756:  1720:  1669:  1661:  1625:  1615:  1569:  1534:  1524:  1485:  1477:  1434:  1399:  1389:  1350:  1308:  1264:  1223:  1182:  1172:  1158:: 18. 1131:  1121:  1073:  1025:  1015:  964:  956:  907:  897:  848:  840:  805:  797:  762:  724:  426:VEGFR2 409:VEGFR1 1879:S2CID 1667:S2CID 1483:S2CID 1244:Blood 846:S2CID 803:S2CID 460:CXCR4 443:TIE-2 392:CD117 375:CD105 324:CD115 290:CD146 256:CD133 62:- or 1920:PMID 1871:PMID 1836:PMID 1795:PMID 1754:PMID 1718:PMID 1659:PMID 1623:PMID 1567:ISBN 1532:PMID 1475:PMID 1432:PMID 1397:PMID 1348:PMID 1306:ISSN 1292:2014 1262:PMID 1221:PMID 1180:PMID 1129:PMID 1071:PMID 1023:PMID 954:ISSN 905:PMID 838:PMID 795:PMID 760:PMID 722:PMID 494:ALDH 485:+/- 482:+/- 471:+/- 403:+/- 358:CD14 341:CD31 315:+/- 312:+/- 298:+/- 295:+/- 281:+/- 278:+/- 273:CD45 250:+/- 247:+/- 244:+/- 239:CD34 166:+/- 163:+/- 93:, a 91:CD14 87:eNOS 26:(or 1910:doi 1863:doi 1826:doi 1785:doi 1781:353 1746:doi 1708:hdl 1698:doi 1651:doi 1613:PMC 1605:doi 1559:doi 1522:PMC 1514:doi 1467:doi 1455:319 1424:doi 1387:PMC 1379:doi 1340:doi 1296:doi 1252:doi 1248:104 1211:doi 1170:PMC 1160:doi 1119:PMC 1111:doi 1107:229 1061:doi 1013:PMC 1003:doi 991:105 962:PMC 944:doi 932:105 895:PMC 885:doi 873:105 830:doi 787:doi 783:275 752:doi 712:doi 659:In 599:ID1 511:LDL 437:++ 318:++ 28:EPC 1964:: 1918:. 1906:17 1904:. 1900:. 1877:. 1869:. 1859:15 1857:. 1834:. 1822:49 1820:. 1816:. 1793:. 1779:. 1775:. 1752:. 1742:15 1740:. 1716:. 1706:. 1694:73 1692:. 1688:. 1665:. 1657:. 1645:. 1621:. 1611:. 1601:70 1599:. 1595:. 1565:, 1553:, 1530:. 1520:. 1510:21 1508:. 1504:. 1481:. 1473:. 1465:. 1453:. 1430:. 1420:13 1418:. 1395:. 1385:. 1375:13 1373:. 1369:. 1346:. 1336:18 1334:. 1304:. 1290:. 1286:. 1274:^ 1260:. 1246:. 1242:. 1219:. 1207:16 1205:. 1201:. 1178:. 1168:. 1154:. 1150:. 1127:. 1117:. 1105:. 1101:. 1083:^ 1069:. 1057:21 1055:. 1051:. 1035:^ 1021:. 1011:. 1001:. 989:. 985:. 960:. 952:. 942:. 930:. 926:. 903:. 893:. 883:. 871:. 867:. 844:. 836:. 826:16 824:. 801:. 793:. 781:. 758:. 748:52 746:. 734:^ 720:. 708:51 706:. 700:. 616:. 522:+ 519:+ 516:+ 509:ac 488:+ 468:+ 465:+ 454:+ 451:+ 448:+ 434:+ 431:+ 420:+ 417:+ 414:+ 400:+ 397:+ 386:+ 383:+ 380:+ 369:- 366:+ 363:+ 352:+ 349:+ 346:+ 335:- 332:+ 329:+ 301:+ 284:- 267:- 264:+ 261:+ 211:+ 208:+ 205:+ 197:+ 194:+ 191:+ 183:+ 180:- 177:- 169:+ 155:+ 152:- 149:- 141:+ 138:- 135:- 1926:. 1912:: 1885:. 1865:: 1842:. 1828:: 1801:. 1787:: 1760:. 1748:: 1724:. 1710:: 1700:: 1673:. 1653:: 1647:7 1629:. 1607:: 1561:: 1538:. 1516:: 1489:. 1469:: 1461:: 1438:. 1426:: 1403:. 1381:: 1354:. 1342:: 1312:. 1298:: 1268:. 1254:: 1227:. 1213:: 1186:. 1162:: 1156:3 1135:. 1113:: 1077:. 1063:: 1029:. 1005:: 997:: 970:. 946:: 938:: 911:. 887:: 879:: 852:. 832:: 809:. 789:: 766:. 754:: 728:. 714:: 597:( 20:.

Index

Endothelial stem cell
endothelial
blood vessels
regenerative medicine
hematopoietic system
hemogenic endothelium
hemangioblast
angioblast
myeloid
monocyte
India ink
eNOS
CD14
lipopolysaccharide
Endothelial colony forming cells
CD34
CD133
CD45
CD146
VE-cadherin
CD115
CD31
CD14
CD105
CD117
VEGFR1
VEGFR2
TIE-2
CXCR4
von Willebrand factor

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑